Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.

Blood
Christopher P VennerAshutosh D Wechalekar

Abstract

Bortezomib has shown great promise in the treatment of amyloid light-chain (AL) amyloidosis. We present our experience of 43 patients with AL amyloidosis who received cyclophosphamide, bortezomib, and dexamethasone (CVD) upfront or at relapse. Of these, 74% had cardiac involvement and 46% were Mayo Cardiac Stage III. The overall hematologic response rate was 81.4%, including complete response (CR) in 41.9% and very good partial response with >90% decrease in difference between involved/uninvolved light chain (VGPR-dFLC) in 51.4%. Patients treated upfront had higher rates of CR (65.0%) and VGPR-dFLC (66.7%). The estimated 2-year progression-free survival was 66.5% for patients treated upfront and 41.4% for relapsed patients. Those attaining a CR or VGPR-dFLC had a significantly better progression-free survival (P=.002 and P=.026, respectively). The estimated 2-year overall survival was 97.7% (94.4% in Mayo Stage III patients). CVD is a highly effective regimen producing durable responses in AL amyloidosis; the deep clonal responses may overcome poor prognosis in advanced-stage disease.

References

Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Angela DispenzieriAllan S Jaffe
Feb 5, 2008·Haematologica·Ashutosh D WechalekarJulian D Gillmore
Jan 8, 2010·Current Opinion in Structural Biology·Tali GidalevitzRichard I Morimoto
Jan 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Efstathios KastritisGiovanni Palladini
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria-Victoria MateosJesús F San Miguel
Oct 21, 2010·Leukemia & Lymphoma·Morie A GertzFrancis K Buadi
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer H PinneyJulian D Gillmore
Jul 15, 2011·QJM : Monthly Journal of the Association of Physicians·S W DubreyUNKNOWN Velcade Can2007 Study Group
Aug 16, 2011·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·H LandauR L Comenzo

❮ Previous
Next ❯

Citations

Sep 13, 2013·Current Hematologic Malignancy Reports·Chakra P Chaulagain, Raymond L Comenzo
Oct 30, 2012·Bone Marrow Transplantation·M RosenzweigH Landau
Aug 28, 2013·Nature Reviews. Nephrology·Julian D Gillmore, Philip N Hawkins
Aug 23, 2012·Orphanet Journal of Rare Diseases·Estelle DesportUNKNOWN Centre national de référence pour l’amylose AL et les autres maladies par dépôts d’immunoglobulines monoclonales
Feb 6, 2014·Haematologica·Shameem MahmoodAshutosh Wechalekar
Oct 5, 2013·Haematologica·Giampaolo Merlini, Giovanni Palladini
Dec 19, 2013·Future Cardiology·Taimur Sher, Morie A Gertz
Nov 23, 2013·European Journal of Internal Medicine·Giovanni Palladini, Giampaolo Merlini
Sep 1, 2014·Surgical Pathology Clinics·Nasreen Mohamed, Samih H Nasr
Aug 27, 2014·Proceedings of the National Academy of Sciences of the United States of America·Christina B CooleyR Luke Wiseman
May 15, 2013·Blood·Giampaolo MerliniGiovanni Palladini
Feb 20, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Ahmad R AbuzinadahLawrence Korngut
Dec 24, 2013·Leukemia & Lymphoma·Sajjad HaiderJames J Driscoll
Jan 7, 2014·Expert Review of Cardiovascular Therapy·Syed Wamique YusufMuzaffar H Qazilbash
Oct 27, 2015·Expert Review of Cardiovascular Therapy·Giovanni PalladiniGiampaolo Merlini
Sep 25, 2014·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Ji Yun LeeKihyun Kim
Feb 11, 2016·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Xianghua HuangZhihong Liu
Feb 26, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Frank BridouxArnaud Jaccard
Jan 26, 2016·Critical Reviews in Oncology/hematology·T JelinekR Hajek
Dec 4, 2014·Kidney International·Rabya H SayedHelen J Lachmann
Oct 23, 2015·British Journal of Haematology·Efstathios Kastritis, Meletios A Dimopoulos
Jan 22, 2015·Kidney International·Frank BridouxUNKNOWN International Kidney and Monoclonal Gammopathy Research Group
Sep 17, 2015·Current Cardiology Reports·Michael N VranianMazen Hanna
Jan 9, 2013·British Journal of Haematology·Moshe E Gatt, Giovanni Palladini
Mar 14, 2013·British Journal of Haematology·Jennifer H PinneyJulian D Gillmore
Apr 24, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Inés SayagoJavier Segovia
Aug 1, 2015·Blood·M Teresa Cibeira, Joan Bladé
Feb 5, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M K DavisR M Witteles
Jun 20, 2014·Proteomics. Clinical Applications·Federica Del Monte, Giulio Agnetti
Sep 19, 2015·La Revue de médecine interne·G BaulierP Duffau
Oct 11, 2014·British Journal of Haematology·Ashutosh D WechalekarUNKNOWN BCSH Committee
May 15, 2015·British Journal of Haematology·Maria T CibeiraUNKNOWN PETHEMA cooperative study group
Jun 17, 2015·Journal of Internal Medicine·K S Patel, P N Hawkins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.